Cindy, Here is the Latest On MLSC...Late PM Yesterday
Kerry
Medical Discoveries, Inc., Establishes a New Operating Division: MDI HealthCare Systems
PR Newswire - June 08, 1998 18:39
MLSC %MTC %HEA V%PRN P%PRN
LAYTON, Utah, June 8 /PRNewsire/ -- Medical Discoveries, Inc., (OTC Bulletin Board: MLSC) announced today it has established a new operating division of the company, MDI HeathCare Systems, will focus on the immediate commercialization of new generation of water purification systems for consumer and industrial applications.....
Medical Discoveries, Inc., ("MDI") through its Japan and USA based research and development teams, has been actively engaged in sourcing and developing a new generation of consumer targeted water purification machines based on certain patents in electrolysis technology.
MDI HeathCare Systems will begin marketing an improved electrolysis water purification system for the consumer market. This new device provides both alkaline water (pH range of 10.0) for drinking, and acidic water (pH range 4.0) for washing fruits and vegetables, and cleansing hands and face.
"The creation of MDI HealthCare Systems enables MDI to develop a focused approach toward this new and emerging healthcare market. Water quality is one of the most important aspects of improving and maintaining good health, and the purification and "enhancement" of drinking water utilizing the superior and effective electrolysis technology places MDI in a strong position" stated MDI President and CEO, Lee F. Kulas. "Our increasingly strong intellectual property and proprietary position, coupled with the depth of experience and knowledge of our Japanese and USA based scientific teams have enabled MDI to broaden the scope, fields of interest and market opportunities for our technology. We will continue to expand our horizons and pursue those markets and applications where our technologies provide the opportunities to improve quality of life and offer strong profit potential."
The establishment of MDI HealthCare Systems is part of a corporate strategy to move certain aspects of MDI core technologies into consumer focused, revenue producing, emerging markets, while pursuing FDA approvals on our MDI-P compound targeted at anti-bacterial, anti-fungal and anti-viral (HIV/AIDS) applications.
SOURCE Medical Discoveries, Inc.
/CONTACT: Sales: customer service, 801-771-0523; Press and Analysts Only:
Marlin Toombs, Director, Investor Relations of Medical Discoveries, Inc.,
801-771-0523/
/Web site: mdi-p.com
(MLSC)
|
